Retinal vascular occlusions

IU Scott, PA Campochiaro, NJ Newman, V Biousse - The Lancet, 2020 - thelancet.com
Acute retinal vascular occlusions are common causes of visual impairment. Although both
retinal artery occlusions and retinal vein occlusions are associated with increased age and …

Sustained suppression of VEGF for treatment of retinal/choroidal vascular diseases

PA Campochiaro, A Akhlaq - Progress in retinal and eye research, 2021 - Elsevier
Neovascular age-related macular degeneration (NVAMD) is the most prevalent choroidal
vascular disease, and diabetic retinopathy (DR) and retinal vein occlusion (RVO) are the …

Widefield OCT-angiography and fluorescein angiography assessments of nonperfusion in diabetic retinopathy and edema treated with anti–vascular endothelial …

A Couturier, PA Rey, A Erginay, C Lavia, S Bonnin… - Ophthalmology, 2019 - Elsevier
Purpose To assess change in retinal nonperfusion (NP) after anti–vascular endothelial
growth factor (VEGF) therapy for diabetic macular edema (DME) using 2 different imaging …

Anti–vascular endothelial growth factor agents in the treatment of retinal disease: from bench to bedside

PA Campochiaro, LP Aiello, PJ Rosenfeld - Ophthalmology, 2016 - Elsevier
The association of retinal hypoxia with retinal neovascularization has been recognized for
decades, causing Michaelson to postulate in 1948 that a factor secreted by hypoxic retina …

Retinal nonperfusion characteristics on ultra-widefield angiography in eyes with severe nonproliferative diabetic retinopathy and proliferative diabetic retinopathy

L Nicholson, J Ramu, EW Chan… - JAMA …, 2019 - jamanetwork.com
Importance Threshold of retinal nonperfusion for the development of proliferative diabetic
retinopathy (PDR) is unclear. Objectives To identify a threshold of retinal nonperfusion for …

Retinal vein occlusions preferred practice pattern®

CJ Flaxel, RA Adelman, ST Bailey, A Fawzi, JI Lim… - …, 2020 - aaojournal.org
Background: Retinal vein occlusion (RVO) occurs when there is partial or complete
obstruction of a retinal vein, and it is classified by the location of the occlusion. An …

Anti–vascular endothelial growth factor therapy can improve diabetic retinopathy score without change in retinal perfusion

S Bonnin, B Dupas, C Lavia, A Erginay, M Dhundass… - Retina, 2019 - journals.lww.com
Purpose: To compare the changes in retinal perfusion on ultra–wide-field fluorescein
angiography with the changes in diabetic retinopathy lesions observed on ultra–wide-field …

New developments in the classification, pathogenesis, risk factors, natural history, and treatment of branch retinal vein occlusion

J Li, YM Paulus, Y Shuai, W Fang, Q Liu… - Journal of …, 2017 - Wiley Online Library
For years, branch retinal vein occlusion is still a controversial disease in many aspects. An
increasing amount of data is available regarding classification, pathogenesis, risk factors …

Ultra-wide-field fluorescein angiography in diabetic retinopathy: a narrative review

A Rabiolo, M Parravano, L Querques… - Clinical …, 2017 - Taylor & Francis
Fluorescein angiography (FA) is a useful examination in patients suffering from diabetic
retinopathy (DR). Traditional angiograms explore 30°–50° of the retina at once; however …

Five-year outcomes of retinal vein occlusion treated with vascular endothelial growth factor inhibitors

K Spooner, S Fraser-Bell, T Hong… - BMJ Open …, 2019 - bmjophth.bmj.com
Purpose Report 5-year outcomes of patients receiving anti-vascular endothelial growth
factor (VEGF) for the treatment of macular oedema secondary to retinal vein occlusion (RVO …